中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
Author:(Masakazu HATANO)

1.A Pharmacovigilance Study on Clozapine in the Food and Drug Administration Adverse Event Reporting System: A Regional Comparative Analysis

Masakazu HATANO ; Haruna ARAKI ; Takeo SAITO ; Shigeki YAMADA

Clinical Psychopharmacology and Neuroscience 2024;22(3):442-450

2.Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study.

Masakazu HATANO ; Hiroyuki KAMEI ; Risa INAGAKI ; Haruna MATSUZAKI ; Manako HANYA ; Shigeki YAMADA ; Nakao IWATA

Clinical Psychopharmacology and Neuroscience 2018;16(2):184-189

3.Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

Hiroyuki KAMEI ; Hanae YAMADA ; Masakazu HATANO ; Manako HANYA ; Shigeki YAMADA ; Nakao IWATA

Clinical Psychopharmacology and Neuroscience 2020;18(1):159-163

4.Optimizing preoperative bone health assessment for adult spinal deformity: a prospective correlation analysis of intraoperative pedicle screw insertion torque and imaging modalities in Japan

Keishi MARUO ; Fumihiro ARIZUMI ; Tomoyuki KUSUKAWA ; Masakazu TOI ; Masaru HATANO ; Tetsuto YAMAURA ; Kazuya KISHIMA ; Toshiya TACHIBANA

Asian Spine Journal 2024;18(4):532-540

5.Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with Schizophrenia.

Masakazu HATANO ; Hiroyuki KAMEI ; Azusa KATO ; Ippei TAKEUCHI ; Manako HANYA ; Junji UNO ; Shigeki YAMADA ; Kiyoshi FUJITA ; Nakao IWATA

Clinical Psychopharmacology and Neuroscience 2017;15(2):132-137

6.Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan

Masakazu HATANO ; Ippei TAKEUCHI ; Kanade YAMASHITA ; Aoi MORITA ; Kaori TOZAWA ; Takashi SAKAKIBARA ; Genta HAJITSU ; Manako HANYA ; Shigeki YAMADA ; Nakao IWATA ; Hiroyuki KAMEI

Clinical Psychopharmacology and Neuroscience 2021;19(4):610-617

7.Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia

Hiroyuki KAMEI ; Yuki HOMMA ; Ippei TAKEUCHI ; Genta HAJITSU ; Kaori TOZAWA ; Masakazu HATANO ; Aiko FUKUI ; Manako HANYA ; Shigeki YAMADA ; Nakao IWATA

Clinical Psychopharmacology and Neuroscience 2020;18(1):49-57

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO